A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failure

被引:8
作者
Botello-Flores, Yesica Abril [1 ,2 ]
Yocupicio-Monroy, Martha [2 ]
Balderrabano-Saucedo, Norma [3 ]
Contreras-Ramos, Alejandra [1 ]
机构
[1] Childrens Hosp Mexico Federico Gomez HIMFG, Lab Dev Biol Res & Expt Teratogen, Dr Marquez 162, Mexico City 06720, DF, Mexico
[2] Autonomous Univ Mexico City, Postgrad Genom Sci, Mexico City, DF, Mexico
[3] Childrens Hosp Mexico Federico Gomez HIMFG, Res Lab Cardiomyopathies & Arrhythmias, Mexico City, DF, Mexico
关键词
Systematic review; Heart failure; Heart diseases; Biomarkers; miRNAs; MSCs; Exosomal; MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; HUMAN ADIPOSE-TISSUE; SIGNAL TRANSDUCER; REPERFUSION INJURY; OXIDATIVE STRESS; ACTIVATOR; CARDIOMYOCYTES; APOPTOSIS; CARDIOMYOPATHY;
D O I
10.1007/s11033-022-07385-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background This systematic review summarizes results of studies that evaluated the expression of microRNAs (miRs) in pre-diabetes or type 2 diabetes. Methods The information was obtained in PubMed, EMBL-EBI, Wanfang, Trip Database, Lilacs, CINAHL and Google. A qualitative synthesis of the results was performed and miRs frequency was graphically. From 1880 we identified studies, only 53 fulfilled the inclusion criteria. The 53 studies analyzed miRs in T2D; and of them, thirteen also described data in pre-diabetes. Results In diabetics, 122 miRs were reported and 35 miRs for pre-diabetics. However, we identified that 5 miRs (-122-5p, 144-3p, 210, 375, -126b) were reported more often in diabetics, and 4 (144-3p, -192, 29a and -30d) in pre-diabetics. Conclusions Circulating miRs could be used as biomarkers of type 2 diabetes. However, it is necessary to validate these microRNAs in prospective and multi-center studies, where different population subgroups, considering the age, gender, and risk factors.
引用
收藏
页码:8953 / 8973
页数:21
相关论文
共 91 条
[41]   Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice [J].
Nakamura, Yuto ;
Kita, Shunbun ;
Tanaka, Yoshimitsu ;
Fukuda, Shiro ;
Obata, Yoshinari ;
Okita, Tomonori ;
Nishida, Hiroyuki ;
Takahashi, Yuki ;
Kawachi, Yusuke ;
Tsugawa-Shimizu, Yuri ;
Fujishima, Yuya ;
Nishizawa, Hitoshi ;
Takakura, Yoshinobu ;
Miyagawa, Shigeru ;
Sawa, Yoshiki ;
Maeda, Norikazu ;
Shimomura, Iichiro .
MOLECULAR THERAPY, 2020, 28 (10) :2203-2219
[42]   Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase [J].
Negoro, S ;
Kunisada, K ;
Fujio, Y ;
Funamoto, M ;
Darville, MI ;
Eizirik, DL ;
Osugi, T ;
Izumi, M ;
Oshima, Y ;
Nakaoka, Y ;
Hirota, H ;
Kishimoto, T ;
Yamauchi-Takihara, K .
CIRCULATION, 2001, 104 (09) :979-981
[43]   Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway [J].
Ni, Jie ;
Liu, Yihai ;
Wang, Kun ;
Wu, Mingyue ;
Kang, Lina ;
Sha, Dujuan ;
Xu, Biao ;
Gu, Rong .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 22 :948-956
[44]   Human trophoblast-derived exosomes attenuate doxorubicin-induced cardiac injury by regulating miR-200b and downstream Zeb1 [J].
Ni, Jie ;
Liu, Yihai ;
Kang, Lina ;
Wang, Lian ;
Han, Zhonglin ;
Wang, Kun ;
Xu, Biao ;
Gu, Rong .
JOURNAL OF NANOBIOTECHNOLOGY, 2020, 18 (01)
[45]   Blocking exosomal miRNA-153-3p derived from bone marrow mesenchymal stem cells ameliorates hypoxia-induced myocardial and microvascular damage by targeting the ANGPT1-mediated VEGF/PI3k/Akt/eNOS pathway [J].
Ning, Wenlong ;
Li, Shuhua ;
Yang, Weiguang ;
Yang, Bo ;
Xin, Chuanyou ;
Ping, Xin ;
Huang, Chuanqi ;
Gu, Yan ;
Guo, Longzhe .
CELLULAR SIGNALLING, 2021, 77
[46]   Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis After Myocardial Infarction [J].
Obana, Masanori ;
Maeda, Makiko ;
Takeda, Koji ;
Hayama, Akiko ;
Mohri, Tomomi ;
Yamashita, Tomomi ;
Nakaoka, Yoshikazu ;
Komuro, Issei ;
Takeda, Kiyoshi ;
Matsumiya, Goro ;
Azuma, Junichi ;
Fujio, Yasushi .
CIRCULATION, 2010, 121 (05) :684-U121
[47]   Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart [J].
Osugi, T ;
Oshima, Y ;
Fujio, Y ;
Funamoto, M ;
Yamashita, A ;
Negoro, S ;
Kunisada, K ;
Izumi, M ;
Nakaoka, Y ;
Hirota, H ;
Okabe, M ;
Yamauchi-Takihara, K ;
Kawase, I ;
Kishimoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6676-6681
[48]   A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles [J].
Pachler, Karin ;
Lener, Thomas ;
Streif, Doris. ;
Dunai, Zsuzsanna A. ;
Desgeorges, Alexandre ;
Feichtner, Martina ;
Oeller, Michaela ;
Schallmoser, Katharina ;
Rohde, Eva ;
Gimona, Mario .
CYTOTHERAPY, 2017, 19 (04) :458-472
[49]   Exosomes Derived from Mesenchymal Stem Cells Ameliorate Hypoxia/Reoxygenation-Injured ECs via Transferring MicroRNA-126 [J].
Pan, Qunwen ;
Wang, Yan ;
Lan, Qing ;
Wu, Weiquan ;
Li, Zhenxuan ;
Ma, Xiaotang ;
Yu, Liming .
STEM CELLS INTERNATIONAL, 2019, 2019
[50]   Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway [J].
Passipieri, Juliana A. ;
Kasai-Brunswick, Tais H. ;
Suhett, Grazielle ;
Martins, Andreza B. ;
Brasil, Guilherme V. ;
Campos, Dilza B. ;
Rocha, Nazareth N. ;
Ramos, Isalira P. ;
Mello, Debora B. ;
Rodrigues, Deivid C. ;
Christie, Beatriz B. ;
Silva-Mendes, Bernardo J. ;
Balduino, Alex ;
Sa, Renato M. ;
Lopes, Laudelino M. ;
Goldenberg, Regina C. ;
Campos de Carvalho, Antonio C. ;
Carvalho, Adriana B. .
STEM CELL RESEARCH & THERAPY, 2014, 5